A carregar...
ILF3 promotes gastric cancer proliferation and may be used as a prognostic marker
Interleukin enhancer-binding factor 3 (ILF3) may function as a transcriptional coactivator and has been reported to be involved in tumor proliferation and metastasis; however, its role and clinical value in gastric cancer (GC) remains unclear. To understand the value of ILF3 in GC, a total of 80 mat...
Na minha lista:
| Publicado no: | Mol Med Rep |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6579973/ https://ncbi.nlm.nih.gov/pubmed/31115508 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2019.10229 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|